Coloplast A/S (CBHD) Stock Price & Analysis
CBHD Stock Chart & Stats
- Day’s Range
- CHF 58.50 - CHF 59.77
- 52-Week Range
- CHF 46.32 - CHF 109.67
- Previous Close
- CHF 58.50
- Volume
- N/A
- Average Volume (3M)
- 6
- Market Cap
- CHF 13.38B
- Enterprise Value
- CHF 106.89B
- Total Cash (Recent Filing)
- CHF 729.00M
- Total Debt (Recent Filing)
- CHF 24.26B
- Price to Earnings (P/E)
- 39.3
- Beta
- -0.24
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- 0.71
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 10.66%
Coloplast A/S News
Coloplast’s Restorelle Mesh Study Terminated: What It Means for Investors
Coloplast A/S ($GB:0QBO) announced an update on their ongoing clinical study. Study Overview This study, titled “Real-Life Use of Transabdominal Restorelle® Meshes in Apical Prolapse Repair: an Observational Post-Market Clinical
Coloplast A/S Explores New Horizons with Peristeen Light Clinical Study
Coloplast A/S (($GB:0QBO)) announced an update on their ongoing clinical study. Study Overview: Coloplast A/S is launching an exploratory clinical investigation titled ‘An Explorative Clinical Investigation to Understand the Clinical
Coloplast’s New Catheter Coating Study: A Potential Game-Changer for Patient Comfort
Coloplast A/S (($GB:0QBO)) announced an update on their ongoing clinical study. Coloplast A/S recently completed a clinical study titled Clinical Investigation of a New Coating for Urinary Intermittent Catheters in
CBHD FAQ
What was Coloplast A/S’s price range in the past 12 months?
What is Coloplast A/S’s market cap?
When is Coloplast A/S’s upcoming earnings report date?
How were Coloplast A/S’s earnings last quarter?
Is Coloplast A/S overvalued?
Does Coloplast A/S pay dividends?
What is Coloplast A/S’s EPS estimate?
How many shares outstanding does Coloplast A/S have?
What happened to Coloplast A/S’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Coloplast A/S?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Gavin Wood
- Employees
- 17,213
- Website
- www.coloplast.com
- Address
- Holtedam 1, Humlebæk, ZE, 3050, DK
Coloplast A/S (CBHD) Earnings & Revenues
CBHD Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 5 | 12 |
| Technical Analysis | 3 | 5 | 1 |
| Moving Averages | 1 | 0 | 11 |
